SHC 0.00% 2.5¢ sunshine heart, inc.

Repairs To The Heart: The Needle Or The Knife?, page-2

  1. 2,133 Posts.
    lightbulb Created with Sketch. 12
    Nice to see some support for Robert Honeywell, very well credentialed reading this post

    1beaver
    Comments (99)| + Follow | Send Message
    Bare hope you are having a good day.. U sure do chase SSH. Wonder how does your resume / work experience compare...??

    Keith Williams
    ABOUT
    Keith began his career as a research scientist (developmental biology, biochemistry, molecular biology) at the Australian National University, University of Oxford (UK), the Max Planck Institute for Biochemistry (Munich, Germany) and finally Macquarie University (Sydney) where he held a Chair in Biology and established the Centre for Analytical Biotechnology. Pioneering the area of proteomics (with Marc Wilkins in his group coining the term), Keith established the world’s first government-funded Major National Proteomics Facility (Australian Proteome Analysis Facility) which was involved with industrialising protein science.

    Keith left academe with his team to found Proteome Systems Ltd in 1999 to commercialise proteomics. The company had a strong focus on intellectual property, engineering/technology and bioinformatics. As CEO he led the company to ASX listing in 2004. Since 2005 Keith has been involved in new business development in biotech, e-health and other emerging technologies. Keith sees climate change and sustainable development as a major issue for humankind and also a major business disruptor/risk and opportunity.

    Keith holds a Bachelor Agr Science from the University of Melbourne and a PhD from the Australian National University. He is a Fellow of the Australian Academy of Technological Sciences & Engineering and received an AM (Member of the Order of Australia) for services to the Biotechnology Industry. He has received various industry awards including an Innovation Hero Medal from the Warren Centre for Advanced Engineering.

    With 300 scientific papers and many patents written, Keith has a clear view of innovation in the Biotechnology and Climate/Renewable Energy space. He is not a financial advisor but his perspective adds relevance to decision-making concerning feasibility and investment in technology innovation.

    Me. Just a MHA from Washington Univ in St Louis post grad at UCLA working for HCA and THC.. c- pulse is just a little simple device - that will (for a % of HF pts) extend life and improve quality of life. good enough for me and it will take a couple or three more years. best
 
watchlist Created with Sketch. Add SHC (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.